The Basics of 182182-31-6 | Exatecan Intermediate| Exatecan Intermediate
182182-31-6, also known as Exatecan Intermediate, is an intermediate compound in the synthesis of the anticancer drug exatecan. It is classified as a heterocyclic compound and is used in the pharmaceutical industry.
Synthesis of Exatecan Intermediate
Exatecan Intermediate is synthesized through multiple steps from starting materials, including amines and aldehydes. A key step in the synthesis is the condensation of an amine and an aldehyde to form a Schiff base, which is then cyclized to form a heterocyclic ring. The resulting compound is then converted into Exatecan through additional synthetic steps.
The Properties of Exatecan Intermediate
Exatecan Intermediate is a yellowish solid that is soluble in some organic solvents. It has a molecular weight of 338.38 g/mol and a melting point of approximately 138-139°C. It is important to note that this compound should be handled with caution due to its potential hazards.
Applications of Exatecan Intermediate
The primary application of Exatecan Intermediate is in the synthesis of the anticancer drug Exatecan. This drug has shown promising activity against multiple types of cancer, including breast, lung, and ovarian cancer. The synthesis of Exatecan is complicated and involves multiple steps, of which the creation of Exatecan Intermediate is one.
Safety Considerations
As with all chemical compounds, proper handling and caution should be exercised when working with Exatecan Intermediate. It is important to wear suitable protective equipment, such as gloves and goggles, when handling this compound. It should also be stored in a cool, dry place away from sources of heat and flame.
The Future of Exatecan Intermediate
As research and development in the field of cancer treatment continues, there is a possibility that Exatecan and 182182-31-6 will play a larger role in cancer therapy. Additionally, further advancements in synthetic chemistry could lead to more efficient and cost-effective production of Exatecan Intermediate and the final drug product.
Usage in Research
Exatecan Intermediate is also used in various research settings as a tool for investigating different biochemical pathways and identifying potential drug targets. Researchers can modify the chemical structure of Exatecan Intermediate to make derivatives that have different properties and functions, which can be used to probe the biological mechanisms underlying cancer and other diseases.
Global Market Overview
The global market for Exatecan Intermediate and Exatecan is currently small, but is expected to grow as the demand for cancer therapies increases. The market for Exatecan alone is projected to reach $352 million by 2025, with a compound annual growth rate of 10.8%.
Conclusion
182182-31-6, or Exatecan Intermediate, is an important compound in the synthesis of the anticancer drug Exatecan. It has potential applications in cancer therapy and is also used in research settings to investigate biological pathways. As with all chemical compounds, proper handling and caution should be exercised.